What Has Been the Progress and Growth of the Genetic Toxicology Testing Market in Recent Years?
The genetic toxicology testing market has seen considerable growth due to a variety of factors.
• The genetic toxicology testing market has experienced substantial growth in recent years. It is projected to expand from $1.63 billion in 2024 to $1.8 billion in 2025, with a compound annual growth rate (CAGR) of 10.4%.
The historical growth is attributed to escalating public health challenges, growing globalization, an increased focus on personalized medicine, a higher demand for comprehensive testing solutions, and a rising number of drug developments.
What Is The Expected Growth In The Genetic Toxicology Testing Market Size Evolve over the Forecast Period?
The genetic toxicology testing market is expected to maintain its strong growth trajectory in upcoming years.
• The genetic toxicology testing market is expected to experience significant growth, reaching $2.64 billion by 2029, at a CAGR of 10.0%.
This growth is driven by the rising demand for testing novel foods, increasing concerns about potential risks, growing environmental and health concerns, more regulatory scrutiny, greater use of in vitro testing methods, and the rise of high-throughput screening platforms. Key trends include advancements in precision medicine and toxicogenomics, better risk communication, evolving testing methodologies, risk assessment improvements, integration of omics technologies, and advancements in genomics and molecular biology.
What Main Forces Are Fueling Expansion In The Genetic Toxicology Testing Market?
The genetic toxicology testing market is expected to benefit from the rising demand for personalized medicine. This healthcare model customizes treatments and interventions based on an individual’s genetic makeup and disease risk. The market for personalized medicine is growing due to advances in genetics, improved disease understanding, and the use of biomarker-based diagnostics. Genetic toxicology testing plays a role by providing data on genetic variability, susceptibility to harmful agents, and treatment responses. For example, in 2023, the FDA approved 16 new personalized medicines for rare diseases, up from six in 2022, according to the Personalized Medicine Coalition. Thus, the demand for personalized medicine is fueling the genetic toxicology testing market.
What Are The Primary Segments In The Global Genetic Toxicology Testing Market?
The genetic toxicology testing market covered in this report is segmented –
1) By Type: In Vitro, In Vivo
2) By Product: Services, Reagents And Consumables, Assays
3) By Application: Healthcare Industry, Food Industry, Cosmetics Industry, Agriculture Industry, Other Applications
Subsegments:
1) By In Vitro: Ames Test, Micronucleus Assay, Comet Assay, Chromosomal Aberration Test, Cell Transformation Assay, Other In Vitro Methods
2) By In Vivo: Micronucleus Test (Rodent), Comet Assay (In Vivo), Bone Marrow Chromosomal Aberration Test, Dominant Lethal Test (Rodent), Other In Vivo Methods
Pre-Book The Genetic Toxicology Testing Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Shaping The Genetic Toxicology Testing Market?
Major players in the genetic toxicology testing market are seeking to enhance accuracy and efficiency in identifying potential genetic toxins by creating novel drug screening platforms, such as phenotypic drug screening. This method involves testing compounds based on their capacity to elicit a specific cellular or physiological response in an entire organism or a relevant cell system, and is typically employed in drug discovery. Case in point, Creative Biogene, a biotechnology firm from the US, introduced zebrafish disease models in August 2022 to aid drug discovery and toxicology research. These models are engineered to simulate human genetic diseases in zebrafish, in order to gain insights into disease development, drug discovery, and toxicology. The zebrafish models from Creative Biogene prove to be a significant resource for gauging drug toxicity, projecting the safety of novel compounds, and to assist in drug development.
Who Are the Key Players In The Genetic Toxicology Testing Market?
Major companies operating in the genetic toxicology testing market are:
• F. Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Merck KGaA
• Laboratory Corporation of America Holdings
• Quest Diagnostics Incorporated
• Eurofins Scientific SE
• SGS SA
• WuXi AppTec
• Intertek Group plc
• Charles River Laboratories International Inc.
• PerkinElmer Inc.
• Bio-Rad Laboratories Inc.
• Fraunhofer ITEM
• Jubilant Life Sciences Limited
• Evotec SE
• Inotiv Inc.
• Promega Corporation
• Syngene International Limited
• Nelson Laboratories LLC
• Instem
• Frontage Laboratories Inc.
• Creative Bioarray
• Creative Biolabs Inc.
• Gentronix Limited
• MB Research Laboratories
What Is The Most Dominant Region In The Genetic Toxicology Testing Market?
North America was the largest region in the genetic toxicology testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genetic toxicology testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
